These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Quantitative Clinical Imaging Methods for Monitoring Intratumoral Evolution. Kim JY; Gatenby RA Methods Mol Biol; 2017; 1513():61-81. PubMed ID: 27807831 [TBL] [Abstract][Full Text] [Related]
4. MRI study identifies three subtypes of glioblastoma. Brower V Lancet Oncol; 2015 Oct; 16(13):e484. PubMed ID: 26365415 [No Abstract] [Full Text] [Related]
5. Somatic mutations associated with MRI-derived volumetric features in glioblastoma. Gutman DA; Dunn WD; Grossmann P; Cooper LA; Holder CA; Ligon KL; Alexander BM; Aerts HJ Neuroradiology; 2015 Dec; 57(12):1227-37. PubMed ID: 26337765 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the growth dynamics of angiogenesis-dependent and -independent experimental glioblastomas by multimodal small-animal PET and MRI. Viel T; Talasila KM; Monfared P; Wang J; Jikeli JF; Waerzeggers Y; Neumaier B; Backes H; Brekka N; Thorsen F; Stieber D; Niclou SP; Winkeler A; Tavitian B; Hoehn M; Bjerkvig R; Miletic H; Jacobs AH J Nucl Med; 2012 Jul; 53(7):1135-45. PubMed ID: 22689925 [TBL] [Abstract][Full Text] [Related]
7. From K-space to Nucleotide: Insights Into the Radiogenomics of Brain Tumors. Elshafeey N; Hassan I; Zinn PO; Colen RR Top Magn Reson Imaging; 2017 Feb; 26(1):33-41. PubMed ID: 28079715 [TBL] [Abstract][Full Text] [Related]
8. Radiomics for precision medicine in glioblastoma. Aftab K; Aamir FB; Mallick S; Mubarak F; Pope WB; Mikkelsen T; Rock JP; Enam SA J Neurooncol; 2022 Jan; 156(2):217-231. PubMed ID: 35020109 [TBL] [Abstract][Full Text] [Related]
9. Radiogenomics as an Integrated Approach to Glioblastoma Precision Medicine. Sanchez I; Rahman R Curr Oncol Rep; 2024 Oct; 26(10):1213-1222. PubMed ID: 39009914 [TBL] [Abstract][Full Text] [Related]
10. Image-driven modeling of the proliferation and necrosis of glioblastoma multiforme. Patel V; Hathout L Theor Biol Med Model; 2017 May; 14(1):10. PubMed ID: 28464925 [TBL] [Abstract][Full Text] [Related]
11. Radiomics, mirnomics, and radiomirRNomics in glioblastoma: defining tumor biology from shadow to light. Maggio I; Franceschi E; Gatto L; Tosoni A; Di Nunno V; Tonon C; Brandes AA Expert Rev Anticancer Ther; 2021 Nov; 21(11):1265-1272. PubMed ID: 34433354 [TBL] [Abstract][Full Text] [Related]
12. Noninvasive Glioblastoma Testing: Multimodal Approach to Monitoring and Predicting Treatment Response. Verduin M; Compter I; Steijvers D; Postma AA; Eekers DBP; Anten MM; Ackermans L; Ter Laan M; Leijenaar RTH; van de Weijer T; Tjan-Heijnen VCG; Hoeben A; Vooijs M Dis Markers; 2018; 2018():2908609. PubMed ID: 29581794 [TBL] [Abstract][Full Text] [Related]
13. The temporal correlation of dynamic contrast-enhanced magnetic resonance imaging with tumor angiogenesis in a murine glioblastoma model. Veeravagu A; Hou LC; Hsu AR; Cai W; Greve JM; Chen X; Tse V Neurol Res; 2008 Nov; 30(9):952-9. PubMed ID: 18662497 [TBL] [Abstract][Full Text] [Related]
14. Imaging Genetic Heterogeneity in Glioblastoma and Other Glial Tumors: Review of Current Methods and Future Directions. Chow D; Chang P; Weinberg BD; Bota DA; Grinband J; Filippi CG AJR Am J Roentgenol; 2018 Jan; 210(1):30-38. PubMed ID: 28981352 [TBL] [Abstract][Full Text] [Related]
15. Radiogenomics of Glioblastoma: Machine Learning-based Classification of Molecular Characteristics by Using Multiparametric and Multiregional MR Imaging Features. Kickingereder P; Bonekamp D; Nowosielski M; Kratz A; Sill M; Burth S; Wick A; Eidel O; Schlemmer HP; Radbruch A; Debus J; Herold-Mende C; Unterberg A; Jones D; Pfister S; Wick W; von Deimling A; Bendszus M; Capper D Radiology; 2016 Dec; 281(3):907-918. PubMed ID: 27636026 [TBL] [Abstract][Full Text] [Related]
16. Radiomic Phenotyping in Brain Cancer to Unravel Hidden Information in Medical Images. Abrol S; Kotrotsou A; Salem A; Zinn PO; Colen RR Top Magn Reson Imaging; 2017 Feb; 26(1):43-53. PubMed ID: 28079714 [TBL] [Abstract][Full Text] [Related]
17. Imaging signatures of glioblastoma molecular characteristics: A radiogenomics review. Fathi Kazerooni A; Bakas S; Saligheh Rad H; Davatzikos C J Magn Reson Imaging; 2020 Jul; 52(1):54-69. PubMed ID: 31456318 [TBL] [Abstract][Full Text] [Related]
18. CXCR4 expression is elevated in glioblastoma multiforme and correlates with an increase in intensity and extent of peritumoral T2-weighted magnetic resonance imaging signal abnormalities. Stevenson CB; Ehtesham M; McMillan KM; Valadez JG; Edgeworth ML; Price RR; Abel TW; Mapara KY; Thompson RC Neurosurgery; 2008 Sep; 63(3):560-9; discussion 569-70. PubMed ID: 18812968 [TBL] [Abstract][Full Text] [Related]
19. Radiological features combined with IDH1 status for predicting the survival outcome of glioblastoma patients. Wang K; Wang Y; Fan X; Wang J; Li G; Ma J; Ma J; Jiang T; Dai J Neuro Oncol; 2016 Apr; 18(4):589-97. PubMed ID: 26409566 [TBL] [Abstract][Full Text] [Related]
20. Prognostic Imaging Biomarkers in Glioblastoma: Development and Independent Validation on the Basis of Multiregion and Quantitative Analysis of MR Images. Cui Y; Tha KK; Terasaka S; Yamaguchi S; Wang J; Kudo K; Xing L; Shirato H; Li R Radiology; 2016 Feb; 278(2):546-53. PubMed ID: 26348233 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]